Bio-Gene Technology Ltd (BGT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.811x

Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has a cash flow conversion efficiency ratio of -0.811x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-946.61K ≈ $-669.78K USD) by net assets (AU$1.17 Million ≈ $825.57K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Bio-Gene Technology Ltd for the company's overall valuation and market capitalisation.

Bio-Gene Technology Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Bio-Gene Technology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Gene Technology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Gene Technology Ltd ranked by their cash flow conversion efficiency. See BGT operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Aldrich Resources Bhd KLSE:0079	-0.587x
Groupe Airwell Société anonyme PA:ALAIR	-0.126x
Addex Therapeutics Ltd SW:ADXN	-0.233x
Revelation Biosciences Inc NASDAQ:REVB	-0.254x
Sabre Resources Ltd AU:SBR	-0.032x
Aeon Metals Ltd AU:AML	-0.016x
Intelligent Group Limited Ordinary Shares NASDAQ:INTJ	-0.001x
Movinn AS CO:MOVINN	0.021x

Annual Cash Flow Conversion Efficiency for Bio-Gene Technology Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025. View BGT live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.63 Million ≈ $1.15 Million	AU$-2.54 Million ≈ $-1.80 Million	-1.563x	-58.38%
2024-06-30	AU$2.79 Million ≈ $1.97 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.987x	+2.98%
2023-06-30	AU$3.22 Million ≈ $2.28 Million	AU$-3.28 Million ≈ $-2.32 Million	-1.017x	-14751.29%
2022-06-30	AU$6.27 Million ≈ $4.44 Million	AU$43.52K ≈ $30.79K	0.007x	+101.61%
2021-06-30	AU$4.25 Million ≈ $3.00 Million	AU$-1.83 Million ≈ $-1.29 Million	-0.430x	-56.90%
2020-06-30	AU$6.00 Million ≈ $4.25 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.274x	+38.40%
2019-06-30	AU$4.95 Million ≈ $3.50 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.445x	-29.44%
2018-06-30	AU$6.91 Million ≈ $4.89 Million	AU$-2.37 Million ≈ $-1.68 Million	-0.344x	-327.50%
2017-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-729.15K ≈ $-515.92K	-0.080x	+90.93%
2016-06-30	AU$473.35K ≈ $334.92K	AU$-419.35K ≈ $-296.71K	-0.886x	-440.17%
2014-06-30	AU$290.03K ≈ $205.21K	AU$-47.57K ≈ $-33.66K	-0.164x	--

About Bio-Gene Technology Ltd

AU:BGT Australia Biotechnology

Market Cap

$3.89 Million

AU$5.49 Million AUD

Market Cap Rank

#29158 Global

#1611 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.34